Genomic medicine implementation: Learning by example
暂无分享,去创建一个
[1] M. Eccles,et al. Welcome to Implementation Science , 2006, Implementation Science.
[2] S. Mallal,et al. HLA-B*5701 screening for hypersensitivity to abacavir. , 2008, The New England journal of medicine.
[3] S. Shirasawa,et al. KRAS mutation confers resistance to antibody‐dependent cellular cytotoxicity of cetuximab against human colorectal cancer cells , 2014, International journal of cancer.
[4] Aniwaa Owusu Obeng,et al. Clinical pharmacogenetics implementation: Approaches, successes, and challenges , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.
[5] Siobhan M. Dolan,et al. Evaluation of a Novel Electronic Genetic Screening and Clinical Decision Support Tool in Prenatal Clinical Settings , 2014, Maternal and Child Health Journal.
[6] Acog Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists Use of Psychiatric Medications During Pregnancy and Lactation , 2009 .
[7] Soma Das,et al. Adoption of a clinical pharmacogenomics implementation program during outpatient care–initial results of the University of Chicago “1,200 Patients Project” , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.
[8] T. Kauf,et al. Economic Efficiency of Genetic Screening to Inform the Use of Abacavir Sulfate in the Treatment of HIV , 2012, PharmacoEconomics.
[9] Gail P Jarvik,et al. Return of results: Ethical and legal distinctions between research and clinical care , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.
[10] Michel Wensing,et al. What drives change? Barriers to and incentives for achieving evidence‐based practice , 2004, The Medical journal of Australia.
[11] E. Green,et al. Leading the way to genomic medicine , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.
[12] Peter Tarczy-Hornoch,et al. Refining the structure and content of clinical genomic reports , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.
[13] K. Sangkuhl,et al. Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450–2C19 (CYP2C19) Genotype and Clopidogrel Therapy , 2011, Clinical pharmacology and therapeutics.
[14] Ching-Hon Pui,et al. PG4KDS: A model for the clinical implementation of pre‐emptive pharmacogenetics , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.
[15] Kensaku Kawamoto,et al. Characterizing genetic variants for clinical action , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.
[16] Eric D Wieben,et al. Implementing individualized medicine into the medical practice , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.
[17] Marc S. Williams,et al. Implementation of genomic medicine in a health care delivery system: A value proposition? , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.
[18] Marc S. Williams. Delivery of Personalized Medicine in an Integrated Healthcare System , 2013 .
[19] H. Faruki,et al. HLA-B*5701 screening for hypersensitivity to abacavir. , 2008, Personalized medicine.
[20] Carlo Gambacorti-Passerini,et al. Part I: Milestones in personalised medicine--imatinib. , 2008, The Lancet. Oncology.